The FDA finalized a rule April 29 to treat laboratory-developed tests as medical devices, putting them in the purview of federal oversight. Under the new rules, the FDA will phase in oversight of ...
The Food and Drug Administration on Monday finalized a rule to regulate most tests developed in a lab, in a move that observers expect will face legal challenges and prompt intervention from Congress.
A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug Administration's (FDA) misbegotten effort to regulate laboratory-developed ...
Laboratories are just beginning to assess the magnitude of operational changes needed to comply with a new federal rule expanding regulatory oversight of lab developed tests (LDTs). In a major shift, ...
This article originally appeared on ProPublica. The Big Story newsletter to receive stories like this one in your inbox. The Food and Drug Administration issued a rule on Monday that brings new ...
Dedicated to achieving better health through laboratory medicine, ADLM (formerly AACC) brings together more than 70,000 clinical laboratory professionals, physicians, research scientists, and business ...
A national trade group representing laboratories filed a lawsuit against the FDA on May 29, arguing the agency’s recent final rule to treat laboratory-developed tests as medical devices exceeds its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results